Skip to content

Effects of laser therapy associated or not with mirror therapy on the functionality of the upper limbs and cognition of individuals who have suffered a Stroke

Effects of Transcranial Laser Therapy associated or not with mirror therapy on the functionality of upper limbs and cognition in individuals affected by Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2why5rd
Enrollment
Unknown
Registered
2025-01-30
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

This is a prospective randomized clinical study. 30 patients with diagnosed with Chronic Stroke and randomized into 3 groups: Transcranial Lasertherapy (n=10), Mirror Therapy (n=10), Transcranial Lase
E02.594

Sponsors

Universidade Federal de Alfenas
Lead Sponsor
Universidade Federal de Alfenas
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Both sexes; older than 18 years; clinical diagnosis of stroke in the chronic phase (more than six months); up to grade 2 on the Ashworth scale; ability to respond to simple commands using the least affected limb in pre-defined tasks; signed the Free and Informed Consent Form

Exclusion criteria

Exclusion criteria: Not having resources to travel to the study location; diagnosis of Transient Ischemic Attack; plegia; history of seizures and/or use of medication to control them; diagnosis of other associated neurological diseases; pregnancy; do not present motor sequelae in the upper limbs resulting from the stroke

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: It is expected to find favorable results in the functionality of the upper limbs after intervention with laser therapy.;Outcome found 1: No statistical differences were found in intra- and intergroup comparisons for the analyzed variables. The sample size calculation showed an estimated value of n=57 for the control group and n=57 for the intervention group, to carry out a randomized controlled clinical trial.

Secondary

MeasureTime frame
No secondary outcomes were expected.

Countries

Brazil

Contacts

Public ContactLaisa Afonso

Universidade Federal de Alfenas

laisacarolinee_@hotmail.com+55 35 3701-9000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)